Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05987332 |
|---|---|
| Brief Title: | IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma |
| First Submitted : | July 12, 2023 |
| First Submitted that Met QC Criteria : | August 3, 2023 |
| First Posted : | August 14, 2023 |
| Last Update Submitted that Met QC Criteria : | May 7, 2024 |
| Last Update Posted : | May 9, 2024 |